Exciting developments and new approaches in psoriasis
Why sign up with Medthority?
Develop your knowledge with our disease and condition focused Learning Zones
Access content from credible sources, including expert-led commentary, videos, podcasts, and webinars as well as clinical trials, treatment information and guidelines
Personalised dashboard providing updates and recommendations for content within your areas of interest
When it comes to psoriasis, a knowledgeable healthcare professional is highly valued by patients (Pariser et al., 2016). With this in mind, we created The Psoriasis Academy, an online hub featuring succinct and easily accessible information for all healthcare professionals who want to know more about psoriasis and keep up to date with the latest developments.
Related news and insights
Arcutis Biotherapeutics, Inc. announced it has submitted a new drug application (NDA) to the FDA for roflumilast cream for the treatment of mild-to-severe plaque psoriasis.
Arcutis Biotherapeutics, Inc. announced it had enrolled the first patient in its single Phase III clinical trial evaluating topical roflumilast foam (ARQ-154) as a potential treatment for scalp and body psoriasis.